ASAPF.US Aurora Spine Corporation
- Market cap
- USD 4.88M
- P/E
- -
- P/B
- 1.73x
- ROE
- -73.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is ASAPF.US undervalued?
Graham numberThe Graham number of Aurora Spine Corporation cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Aurora Spine Corporation fundamental analysis
No fundamental analysis for Aurora Spine Corporation yet.
Aurora Spine Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Aurora Spine Corporation
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone lumbar fusion device, which is an integrated …
Full company profileAurora Spine Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Aurora Spine Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 5.99M | 8.68M | 11.2M | 8.65M | 10.5M | 14.9M | 14.5M | 17.6M | 18.4M | 16.2M |
| Gross Profit | - | 2.56M | 4.59M | 3.55M | 3.47M | 4.83M | 7.81M | 8.21M | 10.6M | 11.2M | 9.95M |
| Operating Income | - | -2.18M | 91.4K | -1.08M | -1.16M | -2.55M | -1.34M | -1.50M | -485K | -330K | -1.93M |
| EBITDA | - | -1.27M | 860K | -694K | -574K | -1.90M | -469K | -446K | 180K | 508K | -891K |
| Net Income | - | -2.24M | -68.2K | -1.25M | -232K | -2.36M | -1.50M | -1.68M | -1.00M | -731K | -2.08M |
| EPS | - | -0.06 | 0.00 | -0.03 | 0.00 | -0.04 | -0.02 | -0.02 | -0.01 | -0.01 | -0.03 |
| Balance Sheet | |||||||||||
| Total Assets | - | 5.29M | 6.84M | 6.67M | 7.16M | 10.6M | 10.1M | 12.0M | 11.1M | 10.4M | 8.93M |
| Total Liabilities | - | 3.64M | 3.88M | 4.91M | 3.87M | 4.99M | 5.81M | 6.69M | 6.66M | 6.59M | 6.11M |
| Shareholders' Equity | - | 1.65M | 2.96M | 1.77M | 3.28M | 5.57M | 4.32M | 5.30M | 4.40M | 3.81M | 2.83M |
| Cash & Short-term Investments | - | 12.7K | 857K | 445K | 1.71M | 3.17M | 423K | 767K | 826K | 897K | 363K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.65M | -1.15M | 436K | 729.00 | 310K | -2.13M | -1.56M | -935K | 1.06M | 917K | -377K |
| Capital Expenditure | 91.4K | 56.1K | 293K | 287K | 510K | 721K | 873K | 479K | 638K | 544K | 352K |
| Free Cash Flow | - | -1.28M | 143K | -286K | -245K | -2.85M | -2.43M | -1.41M | 420K | 374K | -729K |
| Ratios | |||||||||||
| ROE | - | -135.7% | -2.3% | -70.9% | -7.1% | -42.4% | -34.8% | -31.7% | -22.8% | -19.2% | -73.4% |
| ROA | - | -42.4% | -1.0% | -18.8% | -3.2% | -22.3% | -14.8% | -14.0% | -9.1% | -7.0% | -23.2% |
| Net Profit Margin | - | -37.4% | -0.8% | -11.2% | -2.7% | -22.4% | -10.1% | -11.6% | -5.7% | -4.0% | -12.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Aurora Spine Corporation dividends
Aurora Spine Corporation has not paid dividends in the last 9 fiscal years.
Who owns Aurora Spine Corporation
- Insiders 25.96%
- Institutions 0.00%
- Public & others 74.04%
- Shares outstanding 78.1M
- Free float 58.9M
Aurora Spine Corporation company profile
- Company name
- Aurora Spine Corporation
- Ticker
- ASAPF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- 20 Holly Street, Toronto, ON, Canada, M4S 3B1
- Phone
- 760-424-2004
- Website
- aurora-spine.com
About Aurora Spine Corporation
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone lumbar fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior allograft implant; and SiLO TFX, a titanium implant device for sacroiliac joint fusion. In addition, the company offers Dexa-C, a 3D printed cervical fusion device, which is a porous 3D-printed intervertebral cage that incorporates lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L, a spinal device implanted in the intervertebral body space. Further, it provides TiNano, which offers a product line of lumbar fusion devices. It serves orthopaedic, neuromolecular, pain, and interventional radiological surgeons. The company was founded in 2013 and is headquartered in Toronto, Canada.
Aurora Spine Corporation management
6- Mr. Trent J. NorthcuttFounder, President, CEO & Director · born 1967
- Mr. Chad ClouseChief Financial Officer
- Mr. Laszlo GaramszegiCTO & Founder · born 1971
- Mr. David M. MeyerVP, Chief Legal Officer & Secretary
- Mr. Matt PaxtonExecutive Vice President of Sales
- Matthew GoldstoneChief Commercial Officer